Psyence Biomedical Ltd. (PBM)
(Delayed Data from NSDQ)
$4.09 USD
-0.86 (-17.37%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $4.10 +0.01 (0.24%) 7:18 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Market Cap
As of the previous market close, Psyence Biomedical Ltd. has a market cap of $2.81M, which represents its share price of $4.95 multiplied by its outstanding shares number of 0.57M. As a small-cap company, PBM's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
PBM 4.09 -0.86(-17.37%)
Will PBM be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PBM based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for PBM
Psyence Biomedical files to sell 8M common shares for holders
12 Health Care Stocks Moving In Monday's Intraday Session
Dow Jumps 1%; Tyson Foods Earnings Beat Views
PBM Advances in Psilocybin Study and Strengthens Financial Position
Corporate Update, August 2025 | PBM Stock News